drugset / Trial / NCT01037322

Cannabidiol for Inflammatory Bowel Disease

NCT01037322

Phase 1/2 Completed 20 enrolled Meir Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

There are many anecdotal reports about improvement of Inflammatory bowel diseases (IBD) with cannabis smoking. The most effective anti inflammatory compound known today is cannabidiol. cannabidiol can be extracted from the cannabis plant, it has no central effect and is fat soluble so it can be given as drops in oil. Doses of up to 500mg did not cause any side effects. The aim of the proposed study is to examine in a double blind placebo controlled fashion the effect of cannabidiol on disease activity in patients with IBD.

Timeline

Start
2010-01
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cannabidiol Other / unclassified 5 mg Other